Adverse Outcome Pathway-Informed Integrated Testing to Identify Chemicals Causing Genotoxicity Through Oxidative DNA

Elizabeth Huliganga1,2, Eunnara Cho2, Carol D Swartz3

  • 1Department of Biology, University of Ottawa, Ottawa, Canada.

Insights

This study demonstrates an Adverse Outcome Pathway (AOP)-informed testing strategy using 4-nitroquinoline 1-oxide (4NQO) in human cells. The integrated approach successfully quantifies chemical-induced DNA damage, mutations, and chromosomal aberrations over time.

Area of Science:

  • Toxicology and Molecular Biology
  • Genotoxicity and Risk Assessment
  • Adverse Outcome Pathways (AOPs)

Background:

  • Adverse Outcome Pathways (AOPs) provide a framework for understanding chemical toxicity and interpreting data from new testing methods.
  • AOP #296 links oxidative DNA damage to mutations and chromosomal aberrations, crucial for regulatory decision-making.
  • Evaluating chemicals through established AOPs enhances the reliability of risk assessment.

Purpose of the Study:

  • To develop and validate an integrated testing strategy informed by AOP #296.
  • To assess the genotoxic potential of 4-nitroquinoline 1-oxide (4NQO) using an AOP-based approach.
  • To quantitatively characterize the time- and concentration-dependent effects of 4NQO on DNA damage and mutations.

Main Methods:

  • Human TK6 cells were exposed to 4NQO in a time-series experiment.
  • Oxidative DNA damage and strand breaks were measured using the CometChip assay with and without formamidopyrimidine DNA glycosylase (Fpg).
  • Micronucleus (MN) frequency was analyzed by flow cytometry, and mutations were assessed using duplex sequencing (DS).

Main Results:

  • 4NQO induced concentration- and time-dependent increases in oxidative DNA damage, strand breaks, MN frequency, and mutation frequency.
  • Oxidative DNA damage was detected early, while mutations appeared at later time points (48h).
  • Duplex sequencing identified C > A transversions, consistent with oxidative DNA lesions, and revealed repair of oxidative damage with persistent strand breaks.

Conclusions:

  • The study provides a validated AOP-informed testing strategy for evaluating chemicals via AOP #296.
  • The integrated approach effectively quantifies 4NQO-induced genotoxicity and elucidates the pathway dynamics.
  • Duplex sequencing is confirmed as a valuable tool for mutagenicity assessment within AOP frameworks.

Related Concept Videos

Toxic Reactions: Overview01:26

Toxic Reactions: Overview

When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
Bioactivation and Tissue Toxicity01:25

Bioactivation and Tissue Toxicity

Bioactivation is a metabolic process that transforms less reactive substances into highly reactive metabolites, initiating tissue toxicity. This transformation can lead to various toxic effects, including carcinogenesis and teratogenesis. Reactive metabolites are classified into two main types: electrophiles and free radicals.Electrophiles are electron-deficient species and are produced primarily by the enzyme cytochrome P-450 during the metabolism of compounds containing carbon, nitrogen, or...
Toxicity Testing in Animals01:23

Toxicity Testing in Animals

Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
Spontaneous and Induced Mutations01:30

Spontaneous and Induced Mutations

Spontaneous mutations arise infrequently during DNA replication due to errors in the process. A key factor behind these errors is tautomeric shifts in nitrogenous bases, where bases transition from keto to enol forms or amino to imino forms. This shift can alter base-pairing rules, leading to mutations. Additionally, reactive oxygen species (ROS) arising from aerobic metabolism can damage DNA, resulting in depurination (loss of a purine base) or depyrimidination (loss of a pyrimidine base).